Clinical Trial Update: Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a vaccine therapy to prevent progression to cervical cancer in patients with cervical intraepithelial neoplasia grade 3 has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3 | Phase 2 | Status: COMPLETED